Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

FDA Grants Vertex Kidney Disease Drug Breakthrough Therapy Designation

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.

Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. Click here to read more.
TipRanks on MSN

Leerink ups Vertex Pharmaceuticals to Outperform on stock pullback, solid growth

As previously reported, Leerink upgraded Vertex Pharmaceuticals (VRTX) to Outperform from Market Perform with a price target of $456, down from ...
TipRanks on MSN

Vertex Pharmaceuticals completes enrollment in IA cohort of AMPLITUDE trial

Vertex also announced enrollment completion of the IA cohort of AMPLITUDE, a global Phase 2/3 clinical trial designed to assess the impact of ...
Rock Paper Shotgun

Civilization 7 dev explains how the revamped 4X map generator bolts together continents from Voronoi diagrams

Firaxis and 2K continue to twiddle with Civilization 7's exploration phase, adding new map generators that produce more ...